These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 8835836)

  • 21. Methods of robust design of nonlinear models with an application to pharmacokinetics.
    Foo LK; Duffull S
    J Biopharm Stat; 2010 Jul; 20(4):886-902. PubMed ID: 20496212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The estimation of population pharmacokinetic parameters using an EM algorithm.
    Aarons L
    Comput Methods Programs Biomed; 1993 Sep; 41(1):9-16. PubMed ID: 8275683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-optimal designs for parameter estimation for indirect pharmacodynamic response models.
    Khinkis LA; Krzyzanski W; Jusko WJ; Greco WR
    J Pharmacokinet Pharmacodyn; 2009 Dec; 36(6):523-39. PubMed ID: 19904585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pharmacometric case study regarding the sensitivity of structural model parameter estimation to error in patient reported dosing times.
    Knights J; Rohatagi S
    J Pharmacokinet Pharmacodyn; 2015 Dec; 42(6):627-37. PubMed ID: 26209956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stochastic error whitening algorithm for linear filter estimation with noisy data.
    Rao YN; Erdogmus D; Rao GY; Principe JC
    Neural Netw; 2003; 16(5-6):873-80. PubMed ID: 12850046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curvature-adjusted optimal design of sampling times for the inference of pharmacokinetic compartment models.
    Daimon T; Goto M
    Stat Med; 2007 Jun; 26(14):2799-812. PubMed ID: 17072822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. POPED, a software for optimal experiment design in population kinetics.
    Foracchia M; Hooker A; Vicini P; Ruggeri A
    Comput Methods Programs Biomed; 2004 Apr; 74(1):29-46. PubMed ID: 14992824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.
    Bulitta JB; Landersdorfer CB
    AAPS J; 2011 Jun; 13(2):212-26. PubMed ID: 21374103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design optimisation for pharmacokinetic modeling of a cocktail of phenotyping drugs.
    Nguyen TT; Bénech H; Delaforge M; Lenuzza N
    Pharm Stat; 2016; 15(2):165-77. PubMed ID: 26689604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
    Wang J; Liang WQ; Wu JJ; Pan CM
    Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An effective approach for obtaining optimal sampling windows for population pharmacokinetic experiments.
    Ogungbenro K; Aarons L
    J Biopharm Stat; 2009; 19(1):174-89. PubMed ID: 19127474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bayesian design criteria: computation, comparison, and application to a pharmacokinetic and a pharmacodynamic model.
    Merlé Y; Mentré F
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):101-25. PubMed ID: 8576840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetic analysis of cefditoren pivoxil in pediatric patients with infection.
    Matsumoto K; Sato N; Mitomi N; Shibasaki S
    Jpn J Antibiot; 2013 Dec; 66(6):357-75. PubMed ID: 24649799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics.
    Mentré F; Mallet A; Steimer JL
    Biometrics; 1988 Sep; 44(3):673-83. PubMed ID: 3203126
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A termination criterion for parameter estimation in stochastic models in systems biology.
    Zimmer C; Sahle S
    Biosystems; 2015 Nov; 137():55-63. PubMed ID: 26360409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal experiment design for nonlinear models subject to large prior uncertainties.
    Walter E; Pronzato L
    Am J Physiol; 1987 Sep; 253(3 Pt 2):R530-4. PubMed ID: 3631311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of multiple-trough sampling design and algorithm on the estimation of population and individual pharmacokinetic parameters].
    Ling J; Qian LX; Ding JJ; Jiao Z
    Yao Xue Xue Bao; 2014 May; 49(5):686-94. PubMed ID: 25151742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nonvoxel-based dose convolution/superposition algorithm optimized for scalable GPU architectures.
    Neylon J; Sheng K; Yu V; Chen Q; Low DA; Kupelian P; Santhanam A
    Med Phys; 2014 Oct; 41(10):101711. PubMed ID: 25281950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal initial state for fast parameter estimation in nonlinear dynamical systems.
    Li Q; Jauberthie C; Denis-Vidal L; Cherfi Z
    Comput Methods Programs Biomed; 2019 Apr; 171():109-117. PubMed ID: 27526628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.